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Abstract
Male fertility is declining and an underlying cause may be due to environment-epigenetic interactions in developing sperm,
yet nothing is known of how the epigenome controls gene expression in sperm development. Histone methylation and
acetylation are dynamically regulated in spermatogenesis and are sensitive to the environment. Our objectives were to
determine how histone H3 methylation and acetylation contribute to the regulation of key genes in spermatogenesis. A
germ cell line, GC-1, was exposed to either the control, or the chromatin modifying drugs tranylcypromine (T), an inhibitor
of the histone H3 demethylase KDM1 (lysine specific demethylase 1), or trichostatin (TSA), an inhibitor of histone
deacetylases, (HDAC). Quantitative PCR (qPCR) was used to identify genes that were sensitive to treatment. As a control for
specificity the Myod1 (myogenic differentiation 1) gene was analyzed. Chromatin immunoprecipitation (ChIP) followed by
qPCR was used to measure histone H3 methylation and acetylation at the promoters of target genes and the control,
Myod1. Remarkably, the chromatin modifying treatment specifically induced the expression of spermatogonia expressed
genes Pou5f1 and Gfra1. ChIP-qPCR revealed that induction of gene expression was associated with a gain in gene
activating histone H3 methylation and acetylation in Pou5f1 and Gfra1 promoters, whereas CpG DNA methylation was not
affected. Our data implicate a critical role for histone H3 methylation and acetylation in the regulation of genes expressed
by spermatogonia – here, predominantly mediated by HDAC-containing protein complexes.
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Introduction
The formation of spermatozoa from spermatogonial stem cells
throughout adult life is dependent on a tightly orchestrated cell
differentiation process governed by unique transcriptional pro-
grams and extensive chromatin remodeling [1]. While current
information indicates that male germ cell differentiation is driven
by tight transcriptional regulation [2,3,4,5,6], the epigenetic
modifications and chromatin remodelers underlying the control
of this gene expression are unknown. The epigenetic layer includes
modification of histones such as methylation, acetylation, phos-
phorylation among others, and DNA methylation [7]. Recent
large scale genome profiling experiments have revealed general
roles for histone modifications in gene regulation whereby histone
H3 methylation on lysine 4 (K4) is gene activating, and
methylation on lysine 9 (K9) is gene silencing [8,9]. Overall
histone acetylation is associated to an open chromatin state and
active gene transcription [10,11,12,13,14]. Advancements on the
readout of these specific marks during cell differentiation are just
now being made. For example as embryonic stem cells (ESC)
progress from a pluripotent state to one of specialization, this
process is characterized by the reconfiguration of developmental
genes from a bivalent marking consisting of activating H3K4
trimethylation and repressive H3K27 trimethylation, to a loss of
repressive marks and a gain in gene function [15]. Furthermore,
there is evidence that epigenetic mechanisms such as DNA
methylation underlie the control of expression of key genes such as
Pou5f1 (POU domain class 5 transcription factor 1, also known as
Oct4) and Nanog [16,17].
In the testis, the production of haploid male gametes includes
three phases: mitotic proliferation of spermatogonia, meiotic
reshuffling of the genome to create genetic diversity and
spermiogenesis, where unique morphological changes occur to
transform a haploid, immotile round spermatid to an elongated
spermatozoa, capable of fertilizing an oocyte [18,19]. Spermato-
gonial stem cells either self-renew or differentiate and the lifetime
production of mature spermatozoa is dependent on these stem
cells [20,21]. Inadequate establishment or depletion of the stem
cell pool will lead to reduced sperm output and infertility [2,3,5].
Knockout and knockdown studies have revealed several transcrip-
tion factors and proteins involved in signal transduction that are
key regulators of stem cell biology including Pou5f1 and glial cell
line derived neurotrophic factor family receptor alpha 1 (Gfra1,
also known as GDNF-family receptor a1) [4,22,23,24]. The Pou5f1
transcription factor is strongly expressed in spermatogonia and its
ablation results in apoptosis of primordial germ cells. As
spermatogonia differentiate Pou5f1 expression is downregulated
[6,25,26]. GDNF-family receptor a1 localizes to type A sper-
matogonia including A single, A paired and A aligned and it is co-
expressed with Pou5f1 [4]. Interestingly, knockdown of Gfra1 in the
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testicular stem cell population induced a phenotypic switch
towards spermatogonial differentiation as indicated by a decrease
in proliferation and expression of Pou5f1, as well as an increase in
differentiation markers. Moreover GDNF cell-signaling is critical
in spermatogonial stem cell renewal [4,27]. The epigenetic
mechanisms involved in regulating these key genes in spermato-
genesis are unknown.
Accumulating evidence from gene knockouts has shown that
chromatin modifiers such as histone demethylases, histone
methyltransferases and histone deacetylases have a critical role
in male germ cell development [28,29,30,31,32,33,34]. However
information on gene-specific targets and how these chromatin
modifiers regulate transcriptional processes and differentiation in
spermatogenesis is lacking.
We and others have previously determined that in developing
male germ cells histone methylation is highly dynamic and tightly
controlled [35,36]. It is well established that the histone H3
demethylase KDM1 (also known as LSD1/AOF2/BHC110) and
the histone deacetylase 1 (HDAC1) form a repressor complex and
that their histone modification activities are intimately linked
[37,38,39]. Recently, we have shown that KDM1 is highly
expressed in spermatogonia and acts in a repressor complex
containing HDAC1 [35]. KDM1 is known to remove activating
mono- and dimethylation marks from H3K4, which results in
repression of gene transcription [40]. Conversely, in concert with
the androgen receptor KDM1 targets repressive H3K9 mono- and
dimethylation marks thereby activating target genes [41].
Our working hypothesis was that by inhibiting chromatin
modifiers, KDM1 and HDAC, we would alter the epigenetic
landscape of a cultured male germ cell line, GC-1 [42], and in turn
change gene expression to reveal genes that are regulated by
histone methylation and acetylation. Our specific aim was to
identify key genes in spermatogenesis that may be targets of this
complex and in turn regulated by histone methylation and
acetylation. From a panel of genes known to be expressed in
spermatogenesis we showed that the spermatogonia expressed
genes Pou5f1 and Gfra1 were sensitive to the chromatin modifying
treatment. We then examined how the expression of these genes
was influenced by the levels of histone H3 methylation and
acetylation, and DNA methylation in the gene promoters.
Materials and Methods
Cell Culture
The GC-1 cell line was obtained from ATCC (CRL-2053;
Manassas, VA, USA). GC-1 cells were generated by Hofmann et
al. and originally derived from postnatal day 10 mouse testes.
They have been described as an intermediate spermatogenic cell
type between type B spermatogonia and preleptotene spermato-
cytes due to morphological and gene expression characteristics
[42]. The cells were cultured in DMEM (11965; Invitrogen,
Carlsbad, CA, USA), supplemented with 10% FBS (12484-028;
Invitrogen), 100 U of penicillin/100 mg of streptomycin (15140-
122; Invitrogen) and 100 mM non-essential amino acids (11140-
050; Invitrogen, Carlsbad, CA, USA), and grown in a humidified
atmosphere containing 5% CO2 at 37uC. GC-1 cells were seeded
at 20% of confluence and allowed to grow for 24 hours before
treatment.
The monoamine oxidase inhibitor tranylcypromine (T) has
been reported as a potent suppressor of the enzymatic activity of
KDM1 [43], whereas trichostatin A (TSA) is a well characterized
inhibitor of histone deacetylases [44]. In order to target KDM1
and HDAC1 with T and/or TSA, we examined the influence of
these inhibitors on GC-1 cell viability, morphology and prolifer-
ation. Since trichostatin A is known to induce apoptosis and to
affect cell cycle progression [45,46,47], GC-1 cells were exposed to
varying TSA concentrations (25 nM, 50 nM, 100 nM, and
300 nM) to determine the optimal minimal dose which caused a
reduction in histone H3 acetylation while having the least impact
on cell viability. Treatment with 50 nM TSA was determined as
most efficient – due to global changes in histone H3 acetylation
levels without cytotoxicity (Figure S1). Cell viability was not
altered by T concentrations ranging from 10 mM to 1 mM. A
working concentration of 100 mM T was selected as this dose has
been shown to inhibit KDM1 and cause epigenetic changes at the
promoters of specific genes [43,48]. As has been reported before
[48,49] no global changes in histone methylation occurred
following treatment with T (Figures S1, S2). Medium was removed
and cells were treated for 16 hours with either 100 mM T (13492-
01-8, Biomol, Plymouth Meeting, PA, USA), or 50 nM TSA
(T8552; Sigma-Aldrich, Saint Louis, MO, USA), or 0.000754%
dimethylsulphoxide (DMSO) (D2650; Sigma-Aldrich), the solvent
of TSA, or a cocktail of 100 mM T and 50 nM TSA. After 16 h of
exposure, treated GC-1 cells were morphologically indistinguish-
able from control cells and cell counts after trypan blue staining
Figure 1. KDM1 and HDAC1 form heteromeric complexes in
GC-1 cells. (A) Endogenous KDM1 and HDAC1 were co-immunopre-
cipitated with specific antibodies against KDM1 and HDAC1. Total GC-1
protein extract was used as input control. Immunoglobulin G (IgG),
Rabbit IgG (RIgG), mouse IgG (MIgG). (B) Western blot analyses of
HDAC1 and KDM1 in protein extracts isolated from GC-1 cells grown in
culture medium (control, ctr), or in culture medium containing either
dimethylsulphoxide (DMSO; TSA solvent), or tranylcypromine (T), or
trichostatin A (TSA), or tranylcypromine and TSA (T+TSA). Western blots
were reprobed with an antibody against beta-Actin as a loading control.
Treatment of GC-1 cells with tranylcypromine and TSA does not alter
protein levels of KDM1 and HDAC1.
doi:10.1371/journal.pone.0012727.g001
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revealed no differences in cell viability between treated and control
cells.
Western Blotting
Total protein of control or treated GC-1 cells were extracted
with Laemmli buffer (62.5 mM Tris-HCl, pH 6.8/2% SDS/25%
Glycerol/0.01% Bromophenol blue) containing 5% of b-Mercap-
toethanol. Proteins were resolved by standard SDS-PAGE and
electroblotted onto nitrocellulose membranes as previously
described [35]. The membranes were incubated with the primary
antibody followed by the corresponding horseradish peroxidase-
conjugated secondary antibody (all antibodies are listed in Table
S1). Beta-Actin was used for normalization of KDM1 and
HDAC1 levels, whereas the total amount of histone H3 was used
for normalization of Western blots for histone H3 modifications.
Antibody signals were detected using SuperSignal West Pico
Chemiluminescent Substrate (Thermo Scientific, Rockford, IL,
USA). Band intensities were measured using the AlphaDigiDoc
analysis system (Alpha Innotech Corporation, San Leandro, CA,
USA). If not otherwise indicated each experiment was replicated a
minimum of three times.
Immunoprecipitation Assay
1610‘6 GC-1 cells were harvested in 1 ml modified RIPA
(50 mM Tris-HCl, pH 7.5/300 mM NaCl/1% NP-40/50 mM
NaF (sodium fluoride)/1 mM PMSF/100 mM NaVO3/proteinase
inhibitor cocktail (P8340; Sigma-Aldrich), sonicated (66(5 sec on/
5 sec off), amplitude: 25%) and kept on ice for 30 min. Soluble
extracts were separated by centrifugation at 100006g for 20 min.
250 ml of total cell extract were used for each IP or the
corresponding control and each volume was made up to 500 ml
with RIPA containing the full complement of inhibitors. Then, cell
extracts were pre-cleared for 1 h on protein A-Agarose beads
(Roche Diagnostics, Mannheim, Germany) and collected as
supernatant after centrifugation. The supernatants were incubated
over night at 4uC with either 5 mg of anti-HDAC1 (clone 2E10;
Millipore, Billerica, MA, USA), or 5 mg of anti-KDM1 (Abcam,
Cambridge, MA, USA) antibody, or the appropriate controls,
which included mouse IgG and rabbit IgG (Jackson ImunoR-
esearch Laboratories, West Grove, PA, USA). Protein A-Agarose
beads were pre-adsorbed with 0.05% BSA prior to capturing the
immune complex for 1 h at 4uC. The beads were then washed
three times with RIPA buffer and captured proteins were eluted in
SDS-PAGE sample buffer for Western blot analysis.
Reverse transcription and real-time PCR
Total RNA was extracted using Purezol (BioRad, Hercules, CA,
USA) according to the manufacturer’s instructions. Then, 2 mg of
total RNA was reverse transcribed using the High Capacity cDNA
Reverse Transcription kit, which includes random primers
(Applied Biosystems, Foster City, CA, USA). Primers were
designed using Primer Express software (Applied Biosystems).
Primer information is given in Table S2. PCR reactions were
performed following the Power SYBR Green PCR Master Mix
protocol (Applied Biosystems) with an ABI Prism 7500 apparatus
(Applied Biosystems). The measured amount of each cDNA was
normalized to Gapdh. In order to avoid pseudogene amplification,
Pou5f1 expression was additionally analyzed using the primer
Mm00658129_gH Pou5f1 TaqMan gene expression assay (Applied
Biosystems) and the TaqMan Fast Universal PCR Master
Mix (Applied Biosystems), following manufacturer’s instructions.
The 18S rRNA TaqMan gene expression assay (primer
Hs99999901_s1, Applied Biosystems) was used for normalization.
If not otherwise indicated, each experiment was repeated
independently a minimum of three times, and each sample and
the corresponding negative controls were run in triplicates.
In silico promoter analysis
We performed an in silico analysis using the CSH TRED
database [50,51] (http://rulai.cshl.edu/cgibin/TRED/tred.cgi?
process = home) to localize the transcriptional start sites (TSS) of
Gfra1 (Gfra1 promoter ID 63194) and Myod1 (Myod1 promoter ID
76703), which were concordant with start sites of Gfra1 and Myod1
transcripts as given by ensemble genome browser (http://www.
ensembl.org/index.html) and the UCSC genome browser (http://
genome.ucsc.edu/index.html?org =Mouse&db=mm9&hg-
sid = 125767812).
Chromatin Immunoprecipitation (ChIP) assay followed by
real-time PCR
ChIPs were performed following the optimized instructions to
measure the levels of histone methylation and acetylation at
targeted gene enhancer and promoter regions in GC-1 cells
following treatment. Moreover, ChIP assays were used to confirm
the presence of KDM1- and/or HDAC1- at Pou5f1 and Gfra1 gene
promoters in GC-1 cells. Cells were rinsed with ice-cold PBS once
and fixed in 1% formaldehyde for 10 min at room temperature to
cross-link DNA and proteins. Glycine (0.125 M) was then added
to quench the formaldehyde. Subsequently, the cells were rinsed
twice in ice-cold PBS, scraped and collected by centrifugation at
4uC. Cells were then resuspended in 2 mL of FA lysis buffer
(50 mM HEPES pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% triton
X-100, 0.1% sodium deoxycholate 10%, 0.1% SDS and protease
inhibitor cocktail (P8340; Sigma-Aldrich). The chromatin was
sheared by sonication to an average fragment size of 500 to
1000 bp. 50 mL of sample was removed to serve as input control,
whereas 50 mg of protein was used for each immunoprecipitation,
including IgG and serum controls. After a dilution 1:10 of each
sample with RIPA buffer (50 mM Tris-HCl pH 8, 150 mM NaCl,
2 mM EDTA ph8, 1% NP-40, 0.5% sodium deoxycholate,
0.1%SDS and protease inhibitors), antibodies were added to the
corresponding sample (find detailed antibody information in Table
S1). 20 mL of protein A-Agarose beads (pre-absorbed with BSA
(NEB, Pickering, Ontario, Canada) and sonicated single stranded
Figure 2. Treatment induces Pou5f1 and Gfra1 gene expression in GC-1 cells. QPCR analyses of spermatogenic gene expression in GC-1
cells, either grown in culture medium (control, ctr), or treated with tranylcypromine (T), or trichostatin A (TSA), or dimethylsulphoxid (DMSO; TSA
solvent), or tranylcypromine and TSA (T+TSA). To avoid detection of expressed pseudogenes a TaqMan assay was performed to analyze Pou5f1 gene
expression. Pou5f1 signals were normalized to 18S rRNA. All other genes were analyzed using SYBR green and signals were normalized to Gapdh.
Values shown on the graphs are based on the change in expression in treated cells compared to the level of expression in control cells whereby the
level of expression in control cells was defined as one. Thereby the fold change in expression indicates the ratio of normalized target gene expression
in treated cells over normalized target gene expression in control cells. Data are expressed as mean 6 SEM; *p,0.05, **p,0.01, ***p,0.001. Means
with different letters are significantly different. N indicates the number of independent experiments, and per experiment each sample and the
corresponding negative controls were run in triplicates. Trichostatin A treatment triggers Pou5f1 (A) and Gfra1 (B) gene expression in GC-1 cells.
Treatment causes a slight but significant increase in Krueppel-like factor 4 (Klf4) (F) expression. Zinc finger and BTB domain containing 16 (Zbtb16) (C),
kit oncogene (Kit) (D), cAMP responsive element modulator (Crem) (E), and lactate dehydrogenase C (Ldhc) (G) are not affected by treatment.
doi:10.1371/journal.pone.0012727.g002
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herring sperm DNA (ab46666, Abcam) was added to all samples
that were then rotated overnight at 4uC. After three washings with
a buffer containing 0.1% SDS/1% Triton X-100/2 mM EDTA
pH 8/150 mM NaCl/20 mM Tris-HCl pH 8 and one with a
final wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA
pH 8, 500 mM NaCl, 20 mM Tris-HCl pH 8) the chromatin-
antibody complexes were eluted and the DNA-proteins cross-links
were reversed for all the samples (including the input) at 65uC
overnight in presence of 1 mg of RNase A (Sigma-Aldrich).
Genomic DNA was recovered and purified with the QIAquick
PCR purification kit (Qiagen, Hilden, Germany). Quantitative
real-time PCR amplifications were performed using primers
specific for Pou5f1 and Gfra1 promoters, or Gapdh control primers
(Table S2), which were designed using Primer Express Software
(Applied Biosystems). Primers spanned regions 22281 to 22212
and 2854 to 2781 relative to the Pou5f1 transcription start site,
and 21071 to 2997 and +104 to +179 relative to the putative
Gfra1 transcription start site. In order to analyze a putative
promoter occupancy of KDM1- and/or HDAC1-containig
protein complexes approximately 3000 bp of Pou5f1 and Gfra1
promoter regions were screened by ChIP-qPCR for KDM1- and/
or HDAC1 abundance. Power SYBR Green PCR Master Mix
(Applied Biosystems) was used with an ABI Prism 7500 apparatus
(Applied Biosystems) following manufacturer’s instructions. Rela-
tive quantification of the genomic DNA received by ChIP was
performed with the comparative CT method. Briefly, after
confirmation of the PCR efficiency for each primer pair used in
this study (Table S2), the DCT values were determined by
subtracting the average CT value of the normalized input from the
average CT value of the corresponding IP samples or the IgG and
normal serum controls, respectively. In order to determine the fold
change of target DNA in treated GC-1 cells over target DNA in
DMSO controls, the DDCT was calculated by subtracting the DCT
of the DMSO from the DCT of TSA or TSA and T treated cells.
The amount of target DNA is finally given by the formula 2‘-
(DDCT).
One experiment comprised the following treatments: cells
exposed to DMSO, or TSA, or a cocktail of T and TSA. For
one experiment two independent plates per treatment have been
pooled. Each ChIP was performed on three independent
experiments.
Pyrosequencing
CpG islands in Pou5f1 or Gfra1 promoter regions were identified
with ’’The sequence manipulation suite’’ database (http://www.
bioinformatics.org/sms/index.html) [52] using the method de-
scribed by Gardiner-Garden and Frommer [53]. Promoter
methylation was determined by pyrosequencing for allele
quantification (PSQ H96A, Biotage, Sweden), which is a real-
time sequencing-based DNA analysis that quantifies multiple and
consecutive CpG sites individually. Briefly 1000 ng of sample
DNA was bisulfite treated using the Zymo DNA Methylation Kit
(Zymo research, Orange, CA, USA). Bisulfite treated DNA was
eluted in 10 ml volume and 1 ml of it is used for each PCR. PCR
was performed using 10X PCR buffer, 3.0 mM MgCl2, 200 mM
of each dNTP, 0.2 mM each of forward and reverse primers,
HotStar DNA polymerase (Qiagen) 1.25 U, and ,10 ng of
bisulfite converted DNA per 50 ml reaction. PCR cycling
conditions were: 94uC 15 min; 45 cycles of 94uC 30 s; 53uC
30 s; 72uC 30 s; 72uC 5 min; and then products were held at 4uC.
The PCR was performed with one of the PCR primers
biotinylated to convert the PCR product to single-stranded DNA
templates. The PCR products (each 10 ml) were sequenced by
Pyrosequencing PSQ96 HS System (Biotage AB) following the
manufacturer’s instructions (Biotage, Kungsgatan, Sweden). The
methylation status of each locus was analyzed individually as a T/
C SNP using QCpG software (Biotage, Kungsgatan, Sweden).
Assay design and pyrosequencing sequencing was performed by
EpigenDX (Worcester, MA, USA). The methylation assay
ASY585 covered the region -190 to +26 relative to the Pou5f1
CpG transcriptional start site and the ADS932 assay comprised
the region +26 to +143 relative to the putative Gfra1 transcrip-
tional start site.
Statistical analyses
If not otherwise indicated, all experiments were repeated at least
three times. All values are expressed as means 6 SEM. To detect
significant effects of treatments a one-way analysis of variance
(ANOVA) was performed and to identify differences between
means the Student-Newman-Keuls test was applied.
Results
The KDM1/HDAC1 complex is present in cultured GC-1
In vivo co-immunoprecipitation experiments on total GC-1
protein extracts demonstrated that in this cell line as in the testis
KDM1 is associated with HDAC1 (Figure 1A). To determine
whether targeting of the KDM1/HDAC1 repressor complex by
T and/or TSA altered KDM1 or HDAC1 expression or protein
stability, Western blot analysis was performed on total protein
extracts isolated from GC-1 cells grown in regular culture
medium, or culture medium supplemented with either T, TSA,
DMSO (the solvent of TSA), or T and TSA. Treatment did
not alter KDM1 or HDAC1 protein levels indicating that
targeting the enzymatic activities of KDM1 and HDAC1, either
individually or combined, does not influence their expression
(Figure 1B).
Identification of spermatogenic genes sensitive to
regulation by histone methylation and acetylation by
treatment with trichostatin A and/or tranylcypromine
In order to identify target genes sensitive to the drug treatment
we selected seven genes that have been shown to be expressed at
defined stages of spermatogenesis. The Myod1 gene, which is not
expressed in germ cells, was used as control for specificity of
treatment to ensure that the drug treatments were not creating an
overall more open chromatin state. Under control conditions we
Figure 3. Tranylcypromine and trichostatin A treatment influences posttranslational modifications of histone H3 at Pou5f1
promoter. (A) Schematic representation of the Pou5f1 promoter. Numbers depict the positions of primer pairs used for ChIP-qPCR relative to the
corresponding transcriptional start site. (B,C) Analyses of histone H3 methylation and acetylation levels in the Pou5f1 promoter by ChIP followed by
qPCR in GC-1 cells that have been cultured in the presence of dimethylsulphoxide (DMSO, control, black bars), or trichostatin A (TSA, grey bars), or
both inhibitors, tranylcypromine and TSA (T+TSA, white bars). Signals of target DNA received from DMSO control cells served as base and were
defined as one. Fold change indicates 2‘-(DDCT) of target DNA in treated cells over 2‘-(DDCT) of target DNA in DMSO controls (Y-axis). Epigenetic
modifications are depicted on the X-axis. Data are expressed as mean 6 SEM; *p,0.05, **p,0.01, ***p,0.001. Means with different letters are
significantly different. N indicates the number of independent experiments, and per experiment each sample and the corresponding negative
controls were run in triplicates.
doi:10.1371/journal.pone.0012727.g003
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Figure 4. Tranylcypromine and trichostatin A treatment influences posttranslational modifications of histone H3 at Gfra1
promoter. (A) Schematic representation of the Gfra1 promoter. Numbers depict the positions of primer pairs used for ChIP-qPCR relative to the
corresponding transcriptional start site. (B,C) Analyses of histone H3 methylation and acetylation levels in the Gfra1 promoter by ChIP and qPCR in
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detected very low to no expression of the following spermatogo-
nia markers (Table S3): Pou5f1 [6,54,55], zinc finger and BTB
domain containing 16 (Zbtb16) [3,54], or kit oncogene (Kit),
[56,57,58,59,60]. However, Gfra1 [4,61,62,63,64] was weakly
expressed in untreated GC-1 cells (Table S3). On the other hand
transcripts of the following genes known to be expressed in
spermatocytes were found under control conditions (Table S3):
cAMP responsive element modulator (Crem) [65,66] and in
agreement with Hofmann and co-workers (1992) [42] low levels
of testicular lactate dehydrogenase-C4 isozyme (Ldhc) [67].
Interestingly, Krueppel-like factor 4 (Klf4) is also expressed in
untreated GC-1 cells (Table S3). In the mouse testis, Klf4 is
strongly abundant in round spermatids [68,69], but it is also
found at low levels in cultured spermatogonial stem cells [70].
Remarkably, treatment of GC-1 cells with TSA or TSA in
combination with T induced the expression of spermatogonia cell
markers Pou5f1 (TSA induced a 12.6-fold increase, Figure 2A)
and Gfra1 (TSA, or TSA and T combined induced a 4-fold
increase, Figure 2B) and the maximal expression of Pou5f1 was
induced by a combined treatment of TSA and T (16.8-fold
increase, Figure 2A). There was no induction of Pou5f1 or Gfra1
expression when GC-1 cells were exposed to DMSO or T alone
(Figure 2A,B). Treatment with TSA significantly increased
expression of Gfra1 (4-fold increase) but combined treatment
with TSA and T did not differ from TSA alone (Figure 2B). No
induction or alterations in gene expression of the other marker
genes were observed (Figure 2C–E,G) with the exception of Klf4
where a small but significant increase was detected following
treatment with T (1.4-fold increase) or TSA alone (1.5-fold
increase) and T and TSA combined (1.5-fold increase) (Figure 2F).
(Ct values of genes analyzed in untreated GC-1 cells are
summarized in Table S3. Changes in gene expression due to
treatment are depicted as fold change over control conditions
(untreated GC-1 cells) in Figure 2.)
Trichostatin A treatment alters the epigenetic landscape
at Pou5f1 and Gfra1 promoters
In all experiments performed in this study no differences were
observed between GC-1 cells grown in culture medium and GC-1
cells exposed to DMSO. As the treatment with T alone did not
induce changes in gene expression (Figure 2) or alter global histone
methylation or acetylation levels (Figures S1, S2), we focused on
TSA and the combined treatment of TSA and T in subsequent
experiments to determine gene-specific alterations in histone
methylation, histone acetylation, and DNA methylation at Pou5f1
and Gfra1 gene promoters. GC-1 cells grown in culture medium
supplemented with DMSO were used as the control. To correlate
epigenetic changes at these promoters with changes in gene
expression, we performed chromatin immunoprecipitation (ChIP)
followed by quantitative real-time PCR. The mouse Pou5f1
promoter has been well characterized and comprises defined
regulatory regions (distal enhancer, proximal enhancer, and
proximal promoter) that are critical for its activation [71,72].
To cover the regulatory regions of the Pou5f1 promoter and a
broad region of the Gfra1 promoter, ChIP-qPCR primers were
positioned at intervals of approximately 1000 bp as depicted in
Figures 3A and 4A, respectively. Since DNA fragments of 500–
1000 bp were generated with sonication, epigenetic changes in the
distal enhancer region of the Pou5f1 promoter were detected with
primer pair A (22281 to 22212 relative to TSS), and changes in
the proximal enhancer/proximal promoter region with primer
pair B (2854 to 2781 relative to TSS) (Figure 3A). In order to
identify epigenetic changes in the Gfra1 promoter, primer pair C
(21071 to 2997 relative to TSS) and D (located in the 59UTR of
Gfra1 at +104 to +1011 relative to TSS) were used in qPCR
analyses (Figure 4A).
Using ChIP-qPCR we compared the levels of H3K4 mono- and
dimethylation, H3K9 monomethylation, H3K9 acetylation, and
pan-H3 acetylation at the promoters of Pou5f1 and Gfra1 between
cells treated with either TSA, or TSA and T, or the DMSO
control. Treatment of GC-1 cells with TSA, or TSA in
combination with T significantly increased gene activating histone
H3K4 dimethylation, H3K9 acetylation, and pan-H3 acetylation
marks in the distal enhancer and the proximal enhancer/proximal
promoter region of Pou5f1, whereas levels of H3K4 monomethyla-
tion and H3K9 monomethylation were indistinguishable from
DMSO controls (Figure 3B,C). No enhanced effect on histone
H3K4 methylation was found by treating with TSA in
combination with T.
Analyzing the epigenetic signature of the Gfra1 promoter
region after TSA exposure or the combined treatment of TSA
and T by ChIP-qPCR, we identified a significant increase in
activating H3K9 acetylation and pan-H3 acetylation marks in the
putative promoter region upstream of the TSS and downstream
in the 59UTR of Gfra1 (Figure 4B,C). A slight (approximately
twofold) but significant increase in H3K4 dimethylation was
observed upstream of the Gfra1 TSS using the combined
treatment of TSA and T. There were no alterations in either
H3K4 monomethylation or H3K9 monomethyaltion in this
region (Figure 4B). On the contrary, we identified a slight but
significant decrease in the repressive H3K9 monomethylation
mark in the 59UTR of Gfra1 using TSA alone or in combination
with T, but H3K4 mono- and dimethylation levels were
indistinguishable from the DMSO controls (Figure 4C). Here,
no enhanced effect on histone H3K4- or H3K9 methylation was
found by treating the cells with TSA in combination with T
(Figure 4C).
Effect of tranylcypromine and trichostatin A on gene
expression and the epigenetic landscape of Myod1
To demonstrate specificity of the effects on the expression of
Pou5f1 and Gfra1 following treatment we examined the expression
and epigenetic modifications of myogenic differentiation 1
(Myod1), which is important for muscle development (for review
see [73]) and not expressed in GC-1 cells under control
conditions (Table S4). ChIP analysis of the Myod1 promoter
showed that treatment did not alter H3K4 mono- and
dimethylation or H3K9 methylation. Treatment with TSA or T
and TSA increased H3K9 acetylation (Figure 5). However these
GC-1 cells that have been cultured in the presence of dimethylsulphoxide (DMSO, control, black bars), or trichostatin A (TSA, grey bars), or both
inhibitors, tranylcypromine and TSA (T+TSA, white bars). Signals of target DNA received from DMSO control cells served as base and were defined as
one. Fold change indicates 2‘-(DDCT) of target DNA in treated cells over 2‘-(DDCT) of target DNA in DMSO controls (Y-axis). Epigenetic modifications
are depicted on the X-axis. Data are expressed as mean 6 SEM; *p,0.05, **p,0.01, ***p,0.001. Means with different letters are significantly
different. N indicates the number of independent experiments, and per experiment each sample and the corresponding negative controls were run in
triplicates.
doi:10.1371/journal.pone.0012727.g004
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changes in acetylation alone did not induce Myod1 expression
(Table S4).
Effect of tranylcypromine and trichostatin A on DNA
methylation of CpG islands in Pou5f1 and Gfra1
promoters
It is well known that histone methylation and DNA CpG
methylation are functionally linked [49,74,75,76,77,78]. We
performed bisulfite treatment followed by pyrosequencing to
determine the effect of TSA and T on the DNA methylation status
of Pou5f1 and Gfra1 promoters. Primers used in these assays were
located in the proximal promoter of Pou5f1 (2190 to +26 relative
to TSS) and Gfra1 (+26 to +143 relative to TSS), overlapping or in
closed vicinity with regions analyzed by ChIP-qPCR, which
allowed us to relate the DNA methylation status of the promoter to
the histone methylation and acetylation status and thus changes in
Figure 5. Histone H3 methylation at Myod1 promoter is not affected by tranylcypromine and trichostatin A treatment. (A) Schematic
representation of the Myod1 promoter. Numbers depict the positions of primers used for ChIP-qPCR relative to the corresponding transcriptional
start site. (B) ChIP analyses followed by qPCR reveal changes in the epigenetic landscape of the Myod1 promoter upon treatment. Despite the
increase in H3K9 acetylation, Myod1 is not expressed in untreated GC-1 cells nor induced as a consequence of treatment, as shown in Table S4.
Depicted are histone H3 methylation and acetylation levels in GC-1 cells that have been cultured in the presence of dimethylsulphoxide (DMSO,
control, black bars), or trichostatin A (TSA, grey bars), or both inhibitors, tranylcypromine and TSA (T+TSA, white bars). Signals of target DNA received
from DMSO control cells served as base and were defined as one. Fold change indicates 2‘-(DDCT) of target DNA in treated cells over 2‘-(DDCT) of
target DNA in DMSO controls (Y-axis). Epigenetic modifications are depicted on the X-axis. Data are expressed as mean 6 Stdev; *p,0.05, **p,0.01.
Means with different letters are significantly different. N indicates the number of independent experiments, and per experiment each sample and the
corresponding negative controls were run in triplicates.
doi:10.1371/journal.pone.0012727.g005
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gene expression between treated GC-1 cells and DMSO controls.
Ten CpG dinucleotide positions were assayed for methylation in
the defined region of the Pou5f1 promoter and identified as
hypermethylated (.70% methylation) in all cells, comprising
DMSO controls, or TSA-, or TSA and T treated GC-1 cells
(Figure 6A). Interestingly, depending on the position of the
dinucleotide and the treatment, slight but significant reductions in
CpG methylation could be observed in the assayed Pou5f1
promoter region (Figure 6A). On the contrary, CpG dinucleotides
of the assayed Gfra1 promoter region are slightly methylated as
indicated in Figure 6B. Here, we were not able to detect any
significant changes occurred between treated cells and controls.
KDM1 and HDAC1 occupy Pou5f1 and Gfra1 promoters
in GC-1 cells
ChIP-QPCR was used to confirm that the protein targets of T
and TSA, namely KDM1 and/or HDAC1 interact with Pou5f1
and Gfra1 gene promoters. These assays demonstrated a 17-fold
enrichment of KDM1 in the distal enhancer and a 10-fold
enrichment of KDM1 in the proximal enhancer of the Pou5f1
promoter in GC-1 cells (Figure 7B). HDAC1 was found to be
enriched at the Pou5f1 promoter, namely 3-fold in the distal and 4-
fold in the proximal enhancer region (Figure 7C). Analyzing
KDM1 and HDAC1 occupancy of the Gfra1 promoter in GC-1
cells, we were able to detect a 390-fold enrichment of KDM1 in
the distal (21775 relative to TSS) and a 20-fold enrichment in the
more proximal promoter region (21071 relative to TSS).
Moreover KDM1 was found to be 106-times enriched in the
59UTR of the Gfra1 promoter (Figure 8B). HDAC1 was 3-times
enriched in the distal Gfra1 promoter region, an over 15-fold
enrichment of HDAC1 was detectable in the proximal promoter
region and a 55-fold enrichment in the 59UTR of the Gfra1
promoter (Figure 8C). According to a BLAST search at NCBI
(http://blast.ncbi.nlm.nih.gov/) the antibody used to detect
HDAC1 may have some cross-reactivity with two isoforms of
HDAC1 (XP_001480415.1, XP_001480417.1) which would
impact the results by diluting the signal at the target regions.
These results strongly suggest that KDM1 and HDAC1 occupy
Figure 6. Effect of tranylcypromine and trichostatin A treatment on CpG methylation at Pou5f1 and Gfra1 promoters. DNA was
extracted, treated with bisulfite, amplified by PCR and pyrosequencing was used to determine the bisulfite-converted sequence of CpG sites in (A)
Pou5f1 (positions 2190 to +26 relative to the transcriptional start site) and (B) Gfra1 promoters (positions +26 to +143 relative to the transcriptional
start site). The methylation status of each position is depicted as the mean percentage of ‘‘n’’ independent experiments 6 SEM; *p,0.05, **p,0.01.
Means with different letters are significantly different. Black bars indicate DMSO controls, grey bars depict TSA treated samples and white bars
represent samples that have been exposed to both inhibitors, tranylcypromine and TSA (T+TSA).
doi:10.1371/journal.pone.0012727.g006
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Figure 7. KDM1- and HDAC1-containing protein complexes are located at the Pou5f1 promoter in GC-1 cells. (A) Schematic
representation of the Pou5f1 promoter. Numbers depict the positions of primer pairs used for ChIP-qPCR relative to the corresponding transcriptional
start site. (B,C) ChIP-qPCRs demonstrate occupancy of the Pou5f1 promoter by KDM1- (B) and HDAC1-containing protein complexes (C). ChIP assays
were performed on GC-1 cells that have been cultured in the presence of dimethylsulphoxide using either a specific antibody (recognizing either
KDM1 (black bars) or HDAC1 (grey bars)) or the corresponding IgG controls (white bars), (rabbit IgG = RIgG; mouse IgG = MIgG). Each bar represents
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Pou5f1 and Gfra1 promoters in GC-1 cells and function in the
regulation of expression.
Discussion
In this study we revealed epigenetic mechanisms that are likely
to be involved in the expression of key genes in spermatogonia,
namely Pou5f1 and Gfra1. These experiments implicate histone H3
methylation and acetylation in the regulation of their expression
and suggest that transcription is influenced by HDACs and
KDM1. The underlying molecular mechanisms revealed by
pharmacological treatments of the GC-1 cell line suggest that in
spermatogonia expression of Pou5f1 and Gfra1 is maintained by an
enrichment of histone H3 acetylation and dimethylation of histone
H3 at lysine 4. Based on our results we suggest that as
spermatogonia differentiate the loss of expression of Pou5f1 and
Gfra1 may be concomitant with gene-specific activity of HDACs
and KDM1 and the consequent removal of gene activating histone
H3 acetylation and H3K4 dimethylation. These epigenetic
changes are summarized in a model shown in Figure 9.
Histone acetylation is intimately involved in the epigenetic
regulation of transcription and at a single gene locus a fine balance
of histone acetyltransferase and deacetylase activity controls gene
expression [79,80,81]. Histone hyperacetylation is associated with
an open chromatin state and general transcriptional activity
[10,11,12,13,14]. Inhibition of histone deacetylase activity by TSA
has many faces: it can for instance result in de-differentiation of
primordial germ cells into embryonic germ cells [82], accelerate
murine stem cell differentiation [83], force cancer cells into a
differentiated state [84], or in concert with a DNA methyltrans-
ferase inhibitor convert neurosphere cells into neurosphere-
derived haematopoietic cells [85]. While we did not observe
changes in cell morphology or behavior to indicate the GC-1 cell
line altered its differentiation state, we did observe specific changes
in gene expression that were associated to gene-specific changes in
the epigenetic profile. In the brief time-scale of these experiments
changes in differentiation would not be expected. For example in
the case of induced pluripotent stem cells, virally transduced
pluripotency factors (e.g. Pou5f1, Klf4, Sox2) need to be expressed
for approximately twelve to eighteen days to initiate de-
differentiation and reprogramming of mouse embryonic fibroblast
cells [86].
Interestingly TSA treatment of the GC-1 cell line turned on
specific genes expressed in spermatogonia as we saw an activation
of spermatogonia cell markers Gfra1 and Pou5f1. The lack of
change in expression in the panel of genes examined suggests that
expression of Pou5f1 and Gfra1 is a consequence of gene-specific
epigenetic effects of the HDAC and KDM1 inhibitors and not due
to global changes to the epigenome. In the present study, induced
Pou5f1 expression was associated with increased H3K4 dimethyla-
tion, H3K9 acetylation and pan-H3 acetylation at regulatory
regions of the mouse Pou5f1 promoter. Although we demonstrated
that Pou5f1 expression was maximal under the co-suppression of
KDM1 and HDAC1, a closer look at the epigenetic marks on the
promoter revealed that co-inhibition of HDAC and KDM1 did
not further enhance gene activating H3K4 methylation marks.
Therefore the enhanced gene activation under KDM1/HDAC1
inhibition may be a consequence of indirect KDM1/HDAC1
signaling. We postulate that the inhibition by TSA on HDACs and
the consequent increased H3K4 dimethylation was due to an
indirect effect on KDM1 since TSA does not target demethylases,
but specifically inhibits histone deacetylases by binding to the
catalytic core [87]. Evidence supporting this potential molecular
mechanism comes from experiments showing that hyperacetyla-
tion of lysine residues on histone H3 abolished or attenuated
KDM1 function, and that acetyl groups had to be removed before
H3K4 demethylation by KDM1 occurred [88,89]. Moreover we
detected KDM1 and HDAC at our target genes promoters
suggesting that effects are a consequence of drug action on the
KDM1/HDAC complex.
The gain in histone H3K4 dimethylation at the Pou5f1
promoter and associated gene activation we report here following
HDAC inhibition and under the combined suppression of
KDM1/HDAC is similar to what has been observed in embryonal
carcinoma cells [43]. However, unlike the GC-1 cells, embryonal
carcinoma cells increased Pou5f1 expression when KDM1 was
inhibited by T alone [43]. The differences in cellular response to T
between the embryonal carcinoma cells and GC-1 cell used here
may be due to differences in sensitivity to inhibition of KDM1 by
T. Unlike GC-1 cells, embryonal carcinoma cells express high
levels of KDM1 and have detectable levels of Pou5f1 under control
conditions [43].
Like Pou5f1, the expression of Gfra1 in GC-1 cells seemed to be
directed principally by HDACs since treatment with TSA caused a
strong increase in activating H3K9- and total H3 acetylation in
the Gfra1 promoter region and consequent gene expression. In
contrast to the major changes in acetylation only a slight increase
in gene activating H3K4 dimethylation under the combined
inhibition of KDM1/HDAC1 by TSA and T occurred, and this
was not associated with enhanced expression in comparison to
TSA alone. In this study there was no effect of inhibition of
KDM1 by T alone on global histone modifications or changes in
gene expression. Rather, treatment with T was effective only when
used in combination with TSA. These effects are in line with
previous studies where it has been reported that there was a lack of
globally increased histone H3 methylation after genetic ablation of
KDM1 in murine ES cells [49], and following the suppression of
KDM1 by T, or its knockdown by siRNA in human cervical
cancer cell lines [48]. Taken together these findings suggest that
KDM1 activities are highly gene-specific and likely to involve its
function in a protein complex with HDAC and other proteins.
At some gene promoters there is crosstalk between histone
modifications and DNA methylation. In a previous study Ou and
coworkers associated a TSA induced increase of histone
acetylation, with a significant decrease in global DNA methylation
[90]. It was thereby pertinent to assess the DNA methylation status
at the promoter regions of Pou5f1 and Gfra1. Overall no significant
changes in DNA methylation occurred in either the Pou5f1 or
Gfra1 promoter indicating that histone methylation and acetylation
are the principles means of regulating gene expression at these
promoters in GC-1 cells. However, depending on the treatment
and the position of the CpG dinucleotides we observed a slight but
significant decrease in DNA methylation in the analyzed Pou5f1
promoter region, but none in the Gfra1 promoter. We cannot
completely rule out that the changes in DNA methylation
observed in the Pou5f1 promoter had an impact on the induction
the ChIP-qPCR results of two independent, pooled experiments. Signals of target DNA received from IgG controls served as base and were defined as
one. Fold change represents the 2‘-(DDCT) value, where the normalized IgG signal is subtracted from the normalized signal of the specific antibody.
QPCR results were analyzed on an agarose gel and shown underneath the corresponding graphs.
doi:10.1371/journal.pone.0012727.g007
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Figure 8. KDM1- and HDAC1-containing protein complexes are located at the Gfra1 promoter in GC-1 cells. (A) Schematic
representation of the Gfra1 promoter. Numbers depict the positions of primer pairs used for ChIP-qPCR relative to the corresponding transcriptional
start site. (B,C) ChIP-qPCRs demonstrate occupancy of the Gfra1 promoter by KDM1- (B) and HDAC1-containing protein complexes (C). ChIP assays
were performed on GC-1 cells that have been cultured in the presence of dimethylsulphoxide using either a specific antibody (recognizing either
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of its expression in treated GC-1 cells. But this seems to be unlikely
as .60 to 70% methylation remained following treatment at the
Pou5f1 promoter and low methylation was found on the Gfra1
promoter.
As the mechanisms and interpretation discussed here are based
on a transformed spermatocyte-like cell line, this underlies the
extrapolation to events in vivo. The use of an immortalized cell line
such as the GC-1 holds certain limitations but the positive factors
outweighed the negatives when choosing a model system and
examining the alternatives. The GC-1 cells represent a relatively
homogenous cell line that can be readily and robustly expanded
without being co-cultured with somatic cells, while sustaining germ
cell characteristics [42]. Moreover they are easy to manipulate and
deliver an unlimited source of material, which is critical for ChIP
experiments, which require millions of cells per treatment for
analysis.
Importantly this study has revealed epigenetic mechanisms
likely to be involved in the complex gene regulation in
spermatogenesis. Worth considering is that environmental induced
epigenetic mutations in developing germ cells may have
consequences for lifetime fertility as there is likely to be plasticity
in histone modifications.
Figure 9. Epigenetic remodeling in Pouf5f1 and Gfra1 promoter regions - a proposed model to explain changes in gene expression
in GC-1 cells after Tranylcypromine and TSA treatment. (A) In untreated GC-1 cells (regular growth conditions), repressive epigenetic marks
(e.g. H3K9 methylation and CpG methylation) keep the Pou5f1 promoter silent, by creating a tight chromatin structure and preventing the binding of
the transcription machinery. Multi-protein complexes that contain writers of repressive epigenetic marks, e.g. HDACs and/or HDAC/KDM1, create a
repressive chromatin state. Blocking these enzymes using TSA (targets HDACs) and/or tranylcypromine (represses KDM1) results in the accumulation
of activating epigenetic marks (H3K4 methylation, H3 acetylation), thereby making it accessible for transcription factors and the transcription
machinery, which eventually results in the induction of Pou5f1 expression. (B) Repressive and activating epigenetic marks at the promoter are
responsible for the weak expression of Gfra1 in untreated GC-1 cells. The exposure of GC-1 cells to tranylcypromine and TSA blocks the gene silencing
activities of HDACs and/or HDAC/KDM1 and allows for the accumulation of activating epigenetic marks. Thus the treatment shifts the epigenetic
landscape at the Gfra1 promoter to a more active state and eventually triggers a stronger transcription of Gfra1. Histone deacetylase (HDAC), lysine-
specific demethylase 1 (KDM1), tranylcypromine (T), trichostatin A (TSA).
doi:10.1371/journal.pone.0012727.g009
KDM1 (black bars) or HDAC1 (grey bars)) or the corresponding IgG controls (white bars), (rabbit IgG = RIgG; mouse IgG = MIgG). Each bar represents
the ChIP-qPCR results of two independent, pooled experiments. Signals of target DNA received from IgG controls served as base and were defined as
one. Fold change represents the 2‘-(DDCT) value, where the normalized IgG signal is subtracted from the normalized signal of the specific antibody.
QPCR results were analyzed on an agarose gel and shown underneath the corresponding graph.
doi:10.1371/journal.pone.0012727.g008
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Supporting Information
Table S1 Antibodies used for Western blotting (WB) and
chromatin-immunoprecipitation (ChIP).
Found at: doi:10.1371/journal.pone.0012727.s001 (0.04 MB
DOC)
Table S2 Primers and TaqMan gene expression assays used for
qPCR or ChIP-qPCR.
Found at: doi:10.1371/journal.pone.0012727.s002 (0.07 MB
DOC)
Table S3 qPCR analysis of male germ cell marker gene
expression in untreated GC-1 cells.
Found at: doi:10.1371/journal.pone.0012727.s003 (0.04 MB
DOC)
Table S4 qPCR analysis of MyoD gene expression in untreated
and treated GC-1 cells.
Found at: doi:10.1371/journal.pone.0012727.s004 (0.03 MB
DOC)
Figure S1 Effect of tranylcypromine and trichostatin A on
global Histone H3K4 methylation and H3 acetylation levels.
Western blot analyses of global histone (A) H3K9 acetylation, (B)
pan-H3 acetylation, (C) H3K4 monomethylation, and (D) H3K4
dimethylation on protein extracts isolated from GC-1 cells either
grown in culture medium (control, ctr), or treated with
tranylcypromine (T), trichostatin A (TSA), or dimethylsulphoxid
(DMSO; TSA solvent), or tranylcypromine and TSA (T+TSA). (E)
Histone H3 visualized on a coomassie gel was used for
normalization. Tranylcypromine alone does not affect global H3
acetylation (A,B) or H3K4 methylation (C,D) in GC-1 cells. TSA
exposure causes a global increase in H3K9 (A) and total H3
acetylation (B) and, probably due to an indirect effect [91], H3K4
dimethylation (D). The combined treatment of T+TSA induces a
global increase in H3K4 monomethylation (C), but does not
further enhance the effect on H3 acetylation (A,B) or H3K4
dimethylation (C). Signals from proteins isolated from control cells
served as the base and were defined as one. Fold change indicates
the ratio of signal intensity in treated cells normalized to histone
H3 over signal intensity in control cells normalized histone H3.
Data are expressed as mean 6 SEM; **p,0.01, ***p,0.001.
Means with different letters are significantly different. N indicates
the number of independent experiments.
Found at: doi:10.1371/journal.pone.0012727.s005 (2.21 MB EPS)
Figure S2 Tranylcypromine and trichostatin A do not affect
global histone H3K9 methylation or H3K4 trimethylation levels.
Western blot analyses of global histone (A) H3K9 mono-, (B)
H3K9 di-, (D) H3K9 tri-, and (E) H3K4 trimethylation on protein
extracts isolated from GC-1 cells either grown in culture medium
(control, ctr), or treated with tranylcypromine (T), trichostatin A
(TSA), or dimethylsulphoxid (DMSO; TSA solvent), or tranylcy-
promine and TSA (T+TSA). (C) and (F) Histone H3 visualized on
coomassie gels was used for normalization. Signals achieved with
proteins isolated from control cells served as base and were defined
as one. Fold change indicates the ratio of signal intensity in treated
cells normalized to histone H3 over signal intensity in control cells
normalized histone H3. Data are expressed as mean 6 SEM. N
indicates the number of independent experiments.
Found at: doi:10.1371/journal.pone.0012727.s006 (3.02 MB EPS)
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